| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 02/25/2009 | CN101374516A Use of substituted 2-imidazole of imidazoline derivatives |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495027 drugs that inhibit biosynthesis of bacterial cell walls, such as (5Z)-5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one, used for treatment of bacterial infections, and as parasiticides |
| 02/24/2009 | US7495023 treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis; also inhibiting cathepsins B and L to treat cancer; e.g. 3'-Bromopropiophenone Thiosemicarbazone |
| 02/24/2009 | US7495017 3-(3-Cyclopentyloxy-4-methoxyphenyl)-1H-pyrazole;adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease |
| 02/24/2009 | US7495013 Chemokine receptor modulators or Histamine H1 antagonists; autoimmune, inflammatory, proliferative or hyperproliferative diseases, or immune diseases; Methyl 4-[[4-(2,4dichloro-3-methylphenoxy)-1-piperidinyl]methyl]-alpha-(phenylmethyl)-1-piperidineacetate for example |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/19/2009 | WO2009023664A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009021980A1 α-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS |
| 02/19/2009 | WO2008149382A8 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 02/19/2009 | WO2008130600A3 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 02/19/2009 | WO2008087514A3 Hdac inhibitors |
| 02/19/2009 | US20090048452 (R)-5-[4-(2-Hydroxy-ethoxy)-phenyl]-3-[(S)-1-(6-iodo-1H-benzoimidazol-2-yl)-2-phenyl-ethyl]-imidazolidine-2,4-dione; map kinase inhibitors; antihyperproliferative agents |
| 02/19/2009 | US20090048337 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/19/2009 | US20090048310 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 02/19/2009 | US20090048298 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048263 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048251 4-(1h-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090047246 Novel inhibitors of hepatitis c virus replication |
| 02/19/2009 | US20090045730 Organic electroluminescence device and material for organic electroluminescence device |
| 02/19/2009 | US20090044857 Dye-Sensitized Photoelectric Conversion Device |
| 02/19/2009 | CA2696336A1 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2025669A1 Alpha-alkyl substituted N-acyltryptophanols |
| 02/18/2009 | EP2024362A1 Iap bir domain binding compounds |
| 02/18/2009 | EP2024361A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof |
| 02/18/2009 | EP2024358A1 Substituted spirocyclic cgrp receptor antagonists |
| 02/18/2009 | EP2024357A2 New heterocyclic compounds for the inhibition of integrins and use thereof |
| 02/18/2009 | EP2024333A2 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101370875A Optical recording medium and azo metal chelate compound |
| 02/18/2009 | CN101370805A Novel pyridine derivatives |
| 02/18/2009 | CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/18/2009 | CN101370802A Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 02/18/2009 | CN101370799A Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors |
| 02/18/2009 | CN101370791A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370790A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370789A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |
| 02/18/2009 | CN101367797A Fine purification method for eprosartan |
| 02/18/2009 | CN101367768A N-(2-pyrimidine oxygen based)benzyl sulfonylamines compounds, preparation method and uses thereof |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/17/2009 | US7491831 PPAR active compounds |
| 02/17/2009 | US7491788 blends of polycarbonate copolymers, transesterification catalysts and adjuvants, having heat stability and optical clarity |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491743 Inhibitors of cellular necrosis |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2009 | WO2009021126A2 Benzo-fused thiophene or benzo-fused furan compounds comprising a triphenylene group |
| 02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
| 02/12/2009 | WO2009020095A1 Aromatic amine derivative and organic electroluminescent device using the same |
| 02/12/2009 | WO2009019173A1 Oxime ester photoinitiators |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009002916A3 Processes for preparing benzimidazole thiophenes |
| 02/12/2009 | WO2008152073A3 Piperazine compounds with a herbicidal action |
| 02/12/2009 | WO2008150882A3 Method for post-emergence crabgrass control |
| 02/12/2009 | WO2008127349A3 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 02/12/2009 | WO2008121817A3 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 02/12/2009 | WO2008107480A8 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators |
| 02/12/2009 | US20090044299 Artichoke hybrid named 'PS-H2015' |
| 02/12/2009 | US20090043096 Method of producing aromatic compound |
| 02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 02/12/2009 | US20090042918 Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3 |
| 02/12/2009 | US20090042888 Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042881 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090042730 Substituted Arylketones |
| 02/12/2009 | US20090042227 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use |
| 02/12/2009 | US20090042124 Resist composition containing novel sulfonium compound, pattern-forming method using the resist composition, and novel sulfonium compound |
| 02/12/2009 | US20090041721 Arylalkoxyl hepatitis c virus protease inhibitors |
| 02/12/2009 | US20090041670 Near Infrared Fluorescent Contrast Agent And Method For Fluorescence Imaging |
| 02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |